Subha Karumuthil‐Melethil

969 total citations
28 papers, 725 citations indexed

About

Subha Karumuthil‐Melethil is a scholar working on Genetics, Molecular Biology and Physiology. According to data from OpenAlex, Subha Karumuthil‐Melethil has authored 28 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 14 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Subha Karumuthil‐Melethil's work include Virus-based gene therapy research (9 papers), Immune Cell Function and Interaction (8 papers) and Lysosomal Storage Disorders Research (8 papers). Subha Karumuthil‐Melethil is often cited by papers focused on Virus-based gene therapy research (9 papers), Immune Cell Function and Interaction (8 papers) and Lysosomal Storage Disorders Research (8 papers). Subha Karumuthil‐Melethil collaborates with scholars based in United States, Canada and Japan. Subha Karumuthil‐Melethil's co-authors include Nicolas Pérez, Chenthamarakshan Vasu, Ruobing Li, Radhika Gudi, Benjamin M. Johnson, M. Hanief Sofi, Steven J. Gray, Bellur S. Prabhakar, Mark Holterman and Patrick Thompson and has published in prestigious journals such as The Journal of Immunology, Diabetes and Scientific Reports.

In The Last Decade

Subha Karumuthil‐Melethil

26 papers receiving 718 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Subha Karumuthil‐Melethil United States	18	283	261	218	196	98	28	725
Nicole Dietrich Germany	12	412 1.5×	211 0.8×	217 1.0×	56 0.3×	52 0.5×	14	1.1k
Federica Ungaro Italy	19	646 2.3×	392 1.5×	163 0.7×	77 0.4×	126 1.3×	52	1.3k
Colleen A. Campbell United States	14	426 1.5×	154 0.6×	66 0.3×	82 0.4×	111 1.1×	19	1.2k
Patrizia Costa Italy	11	367 1.3×	187 0.7×	346 1.6×	120 0.6×	89 0.9×	16	1.1k
Ruizhi Feng China	14	407 1.4×	111 0.4×	243 1.1×	45 0.2×	42 0.4×	43	1.0k
Anguo Liu United States	18	467 1.7×	76 0.3×	203 0.9×	71 0.4×	102 1.0×	39	818
Megan E. Bosch United States	13	300 1.1×	51 0.2×	102 0.5×	267 1.4×	73 0.7×	18	651
James W. Baumgartner United States	14	366 1.3×	184 0.7×	124 0.6×	51 0.3×	34 0.3×	14	861
Nagisa Arimitsu Japan	16	489 1.7×	62 0.2×	77 0.4×	137 0.7×	103 1.1×	40	874
Laura Milligan United States	19	867 3.1×	129 0.5×	101 0.5×	80 0.4×	166 1.7×	27	1.5k

Countries citing papers authored by Subha Karumuthil‐Melethil

Since Specialization

Citations

This map shows the geographic impact of Subha Karumuthil‐Melethil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subha Karumuthil‐Melethil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subha Karumuthil‐Melethil more than expected).

Fields of papers citing papers by Subha Karumuthil‐Melethil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subha Karumuthil‐Melethil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subha Karumuthil‐Melethil. The network helps show where Subha Karumuthil‐Melethil may publish in the future.

Co-authorship network of co-authors of Subha Karumuthil‐Melethil

This figure shows the co-authorship network connecting the top 25 collaborators of Subha Karumuthil‐Melethil. A scholar is included among the top collaborators of Subha Karumuthil‐Melethil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subha Karumuthil‐Melethil. Subha Karumuthil‐Melethil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Firnberg, Elad, Sonia Tejada, Samantha A. Yost, et al.. (2025). Directed evolution of liver-detargeted AAV vectors for systemic gene delivery to skeletal muscle and heart. Molecular Therapy — Methods & Clinical Development. 33(4). 101571–101571.

Yang, Jason H., Keith Elliott, Jared B. Smith, et al.. (2025). Enhanced therapeutic potential of a microdystrophin with an extended C-terminal domain. Molecular Therapy — Methods & Clinical Development. 33(3). 101519–101519.

Glenn, Justin D., et al.. (2024). The presence of CpGs in AAV gene therapy vectors induces a plasmacytoid dendritic cell-like population very early after administration. Cellular Immunology. 399-400. 104823–104823. 4 indexed citations

Gudi, Radhika, Nicolas Pérez, Subha Karumuthil‐Melethil, Gongbo Li, & Chenthamarakshan Vasu. (2022). Activation of T cell checkpoint pathways during β‐cell antigen presentation by engineered dendritic cells promotes protection from type 1 diabetes. Immunology. 166(3). 341–356. 2 indexed citations

Karumuthil‐Melethil, Subha, Violeta Zaric, Patrick Thompson, et al.. (2021). Investigating Immune Responses to the scAAV9-HEXM Gene Therapy Treatment in Tay–Sachs Disease and Sandhoff Disease Mouse Models. International Journal of Molecular Sciences. 22(13). 6751–6751. 7 indexed citations

Niibori, Yosuke, Subha Karumuthil‐Melethil, Chunping Qiao, et al.. (2021). Gene therapy using an ortholog of human fragile X mental retardation protein partially rescues behavioral abnormalities and EEG activity. Molecular Therapy — Methods & Clinical Development. 22. 196–209. 18 indexed citations

Niibori, Yosuke, Liang Zhang, Subha Karumuthil‐Melethil, et al.. (2020). Sexually dimorphic patterns in electroencephalography power spectrum and autism-related behaviors in a rat model of fragile X syndrome. Neurobiology of Disease. 146. 105118–105118. 17 indexed citations

Gudi, Radhika, Nicolas Pérez, Benjamin M. Johnson, et al.. (2019). Complex dietary polysaccharide modulates gut immune function and microbiota, and promotes protection from autoimmune diabetes. Immunology. 157(1). 70–85. 43 indexed citations

Gudi, Radhika, Subha Karumuthil‐Melethil, Nicolas Pérez, Gongbo Li, & Chenthamarakshan Vasu. (2019). Engineered Dendritic Cell-Directed Concurrent Activation of Multiple T cell Inhibitory Pathways Induces Robust Immune Tolerance. Scientific Reports. 9(1). 12065–12065. 11 indexed citations

10.

Marshall, Michael S., Duc Nguyen, Emily Rue, et al.. (2018). Long-Term Improvement of Neurological Signs and Metabolic Dysfunction in a Mouse Model of Krabbe’s Disease after Global Gene Therapy. Molecular Therapy. 26(3). 874–889. 45 indexed citations

11.

Tropak, Michael B., Subha Karumuthil‐Melethil, Patrick Thompson, et al.. (2016). Construction of a hybrid β-hexosaminidase subunit capable of forming stable homodimers that hydrolyze GM2 ganglioside in vivo. Molecular Therapy — Methods & Clinical Development. 3. 15057–15057. 43 indexed citations

12.

Thompson, Patrick, et al.. (2016). 363. Improvement of Sandhoff Phenotype Following Intravenous Injection of Adeno-Associated Viral Vector Expressing a Hexosaminidase Isoenzyme in Adult Sandhoff Mice: Preclinical Safety and Efficacy Study. Molecular Therapy. 24. S145–S146. 1 indexed citations

13.

Thompson, Patrick, Subha Karumuthil‐Melethil, Brian L. Mark, et al.. (2016). Systemic Gene Transfer of a Hexosaminidase Variant Using an scAAV9.47 Vector Corrects G _M2 Gangliosidosis in Sandhoff Mice. Human Gene Therapy. 27(7). 497–508. 28 indexed citations

14.

Karumuthil‐Melethil, Subha, M. Hanief Sofi, Radhika Gudi, et al.. (2014). TLR2- and Dectin 1–Associated Innate Immune Response Modulates T-Cell Response to Pancreatic β-Cell Antigen and Prevents Type 1 Diabetes. Diabetes. 64(4). 1341–1357. 25 indexed citations

15.

Karumuthil‐Melethil, Subha, Nicolas Pérez, Ruobing Li, et al.. (2010). Dendritic Cell-Directed CTLA-4 Engagement during Pancreatic β Cell Antigen Presentation Delays Type 1 Diabetes. The Journal of Immunology. 184(12). 6695–6708. 17 indexed citations

16.

Pérez, Nicolas, Subha Karumuthil‐Melethil, Ruobing Li, et al.. (2008). Preferential Costimulation by CD80 Results in IL-10-Dependent TGF-β1+-Adaptive Regulatory T Cell Generation. The Journal of Immunology. 180(10). 6566–6576. 39 indexed citations

17.

Pérez, Nicolas, Subha Karumuthil‐Melethil, Ruobing Li, et al.. (2008). Preferential costimulation by CD80 results in IL‐10 dependent TGF‐beta1+ adaptive regulatory T cell generation. The FASEB Journal. 22(S2). 405–405. 2 indexed citations

18.

Karumuthil‐Melethil, Subha, Nicolas Pérez, Ruobing Li, & Chenthamarakshan Vasu. (2008). Induction of Innate Immune Response through TLR2 and Dectin 1 Prevents Type 1 Diabetes. The Journal of Immunology. 181(12). 8323–8334. 78 indexed citations

19.

Li, Ruobing, Nicolas Pérez, Subha Karumuthil‐Melethil, et al.. (2007). Enhanced Engagement of CTLA-4 Induces Antigen-Specific CD4+CD25+Foxp3+ and CD4+CD25− TGF-β1+ Adaptive Regulatory T Cells. The Journal of Immunology. 179(8). 5191–5203. 42 indexed citations

20.

Li, Ruobing, Nicolas Pérez, Subha Karumuthil‐Melethil, & Chenthamarakshan Vasu. (2007). Bone Marrow Is a Preferential Homing Site for Autoreactive T-Cells in Type 1 Diabetes. Diabetes. 56(9). 2251–2259. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact